JENNIFER BLECK: Open Payments
NPI 1326683350 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,428 in 115 payments from 16 companies in 2025. Trend: 2023 $1,125 · 2024 $2,990 · 2025 $2,428
Food & beverage: $2,356Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $392 |
| Arcutis Biotherapeutics, Inc. | 13 | $342 |
| ABBVIE INC. | 20 | $341 |
| UCB, Inc. | 11 | $228 |
| PFIZER INC. | 12 | $197 |
| Novartis Pharmaceuticals Corporation | 9 | $174 |
| Lilly USA, LLC | 5 | $142 |
| LEO Pharma Inc. | 6 | $134 |
| Galderma Laboratories, L.P. | 6 | $129 |
| Incyte Corporation | 5 | $114 |
Products named: TREMFYA, Zoryve, Bimzelx, SKYRIZI, CIBINQO, DUPIXENT, ADBRY, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
